Jump to navigation
Consolidated statement of cash flows
| | Note | 2014 | 2013 |
| Net cash flows from operating activities |
|
|
|
| Profit before income tax |
|
4,034,563 |
4,044,464 |
| Adjustments: |
|
(2,010,153) |
(5,181,159) |
| Amortisation and depreciation |
|
747,164 |
579,240 |
| (Gains) losses from investing activities |
42 |
(17,629) |
(432,805) |
| Interest and dividends |
42 |
(70,072) |
(526,650) |
| Change in amounts due from banks |
42 |
516,391 |
932,282 |
| Change in trading assets and financial assets designated upon initial recognition at fair value through profit and loss |
42 |
3,636,624 |
(2,777,360) |
| Change in derivative financial instruments (asset) |
42 |
(2,465,578) |
859,701 |
| Change in loans and advances to customers |
42 |
(6,368,592) |
(6,014,711) |
| Change in other assets, inventories and non-current assets held for sale |
42 |
22,298 |
(123,665) |
| Change in amounts due to banks |
42 |
(10,148,916) |
(254,374) |
| Change in derivative financial instruments (liability) |
42 |
2,205,844 |
(635,887) |
| Change in amounts due to customers |
42 |
9,077,138 |
4,704,388 |
| Change in liabilities classified as held for sale |
|
32,084 |
2,880 |
| Change in debt securities in issue |
42 |
797,462 |
542,532 |
| Change in provisions and impairment allowances |
42 |
1,298,353 |
(598,898) |
| Change in other liabilities, liabilities due to insurance operations and |
|
|
|
| subordinated liabilities |
42 |
315,877 |
719,951 |
| Income tax paid |
|
(842,623) |
(1,033,741) |
| Other adjustments |
42 |
(745,978) |
(1,124,042) |
| Net cash generated from/used in operating activities |
|
2,024,410 |
(1,136,695) |
| Net cash flows from investing activities |
|
|
|
| Inflows from investing activities |
|
44,158,212 |
45,064,980 |
| Proceeds from sale of a subsidiary, net of cash disposed |
|
- |
383,561 |
| Proceeds from sale of non-current assets held for sale |
|
- |
25,450 |
| Proceeds from sale and interest on investment securities |
|
44,056,862 |
44,610,734 |
| Proceeds from sale of intangible assets and tangible fixed assets |
|
73,451 |
43,347 |
| Other investing inflows (dividends) |
|
27,899 |
1,888 |
| Outflows from investing activities |
|
(51,861,334) |
(46,096,798) |
| Purchase of subsidiaries, net of cash acquired |
|
(1,797,972) |
(39) |
| Purchase of investment securities |
|
(49,249,230) |
(45,040,357) |
| Purchase of intangible assets and tangible fixed assets |
|
(814,132) |
(1,056,402) |
| Net cash used in investing activities |
|
(7,703,122) |
(1,031,818) |
| Net cash flows from financing activities |
|
|
|
| Proceeds from debt securities in issue |
|
3,569,624 |
2,119,934 |
| Redemption of debt securities in issue |
|
(1,612,922) |
(2,032,020) |
| Dividends paid |
|
(937,500) |
(2,250,000) |
| Repayment of interest from issued debt securities and subordinated loans |
|
(475,673) |
(478,531) |
| Long-term borrowings |
|
15,287,591 |
1,974,081 |
| Repayment of long-term borrowings |
|
(4,782,292) |
(775,844) |
| Net cash generated from/used in financing activities |
|
11,048,828 |
(1,442,380) |
| Net cash flows |
|
5,370,116 |
(3,610,893) |
| of which currency translation differences on cash and cash equivalents |
|
125,680 |
(16,722) |
| Cash and cash equivalents at the beginning of the period |
|
8,884,739 |
12,495,632 |
| Cash and cash equivalents at the end of the period |
42 |
14,254,855 |
8,884,739 |
| of which restricted |
16 |
11,440 |
32,078 |